Long-Term Evaluation of BIIB067 (Tofersen)

Clinical trial NCT03070119 · COMPLETED

Trial details

NCT number: NCT03070119
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

ALS Caused by Superoxide Dismutase 1 (SOD1) Mutation

Start date: 2017-03-08
Primary completion: 2024-08-12
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.